China Universal Asset Management Company’s Bristol-Myers Squibb BMY Stock Holding History

China Universal Asset Management Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.56M	Buy	27,000 +5,400	+25%	+$310K	0.09%	153
2026 Q1	$1.31M	Buy	21,600 +5,600	+35%	+$326K	0.1%	161
2025 Q4	$863K	Buy	16,000 +6,000	+60%	+$289K	0.07%	202
2025 Q3	$451K	Buy	+10,000	New	+$467K	0.04%	257

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

China Universal Asset Management Company's BMY Position: Q2 2026 in Review

China Universal Asset Management Company increased its Bristol-Myers Squibb (BMY) stake by 25% in Q2 2026, buying an estimated $310K and bringing the position to 27,000 shares worth $1.56M. The position accounts for 0.09% of the portfolio, ranked #153.

China Universal Asset Management Company first reported a position in BMY in Q3 2025 and has held it in 4 quarters since. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

China Universal Asset Management Company held 27,000 shares of Bristol-Myers Squibb worth $1.56M as of Q2 2026.
China Universal Asset Management Company bought 5,400 Bristol-Myers Squibb shares in Q2 2026, an estimated $310K.
Bristol-Myers Squibb made up 0.09% of China Universal Asset Management Company's portfolio in Q2 2026, its #153 holding.
China Universal Asset Management Company first reported a position in Bristol-Myers Squibb in Q3 2025 and has held it in 4 quarters since.
954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.